拯阳理劳汤与贝伐珠单抗化疗联合治疗胃癌晚期53例

Zhengyang Lilao Decoction Combined with Bevacizumab Chemotherapy in the Treatment of Advanced Gastric Cancer for 53 Cases

目的分析评价拯阳理劳汤与贝伐珠单抗化疗联合治疗胃癌晚期的疗效。方法此次研究胃癌患者例数为106例,入院治疗时间为2017年5月—2018年4月,将患者分为对照组和观察组,各53例。对照组患者应用贝伐珠单抗化疗,观察组应用拯阳理劳汤与贝伐珠单抗化疗联合治疗。观察2组患者的疗效。结果在治疗的效果方面2组进行对比,观察组有效率比对照组高,差异有统计学意义(P<0.05);治疗后观察组患者的生活质量明显优于对照组(P<0.05),差异有统计学意义。对比2组患者的平均存活时间,观察组显然比对照组存活时间长,差异有统计学意义(P<0.05)。在不良反应发生率方面,观察组低于对照组,P<0.05。结论拯阳理劳汤与贝伐珠单抗化疗联合治疗胃癌晚期的疗效比较好,提高患者治疗有效率,可以降低不良反应发生率,增长存活时间,提高生活质量,值得临床的推广应用。

Objective To evaluate the efficacy of Zhengyang Lilao decoction combined with bevacizumab chemotherapy in the treatment of advanced gastric cancer. Methods 106 patients with gastric cancer were randomly divided into observation group and control group according to different treatment methods. Patients in control group were treated with bevacizumab chemotherapy, while patients in observation group were treated with Zhengyang Lilao decoction combined with bevacizumab chemotherapy. The curative effects of the two groups were observed. Results Two groups of patients with advanced gastric cancer in the treatment effect were compared, the curative effect of the observation group was significantly higher than that of the control group, and the difference between the two groups was statistically significant (P<0.05). After treatment, the quality of life of the observation group patients was significantly higher than that of the control group (P<0.05), and the difference was statistically significant. Compared with the average survival time of the two groups, the survival time of the observation group was obviously longer than that of the control group, and the difference was statistically significant (P<0.05). The incidence of adverse reactions of the observation group was lower than that of the control group, and the difference was statistically significant. Conclusion Zhengyang Lilao decoction combined with bevacizumab chemotherapy is effective in the treatment of advanced gastric cancer. It can improve the efficiency of treatment, reduce the occurrence of adverse reactions, increase the survival time of patients, and improve the quality of life of patients.